These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38947012)

  • 21. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation.
    Rubio CA; Weisburd B; Holderfield M; Arias C; Fang E; DeRisi JL; Fanidi A
    Genome Biol; 2014; 15(10):476. PubMed ID: 25273840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent anti-coronaviral activity of pateamines and new insights into their mode of action.
    Magari F; Messner H; Salisch F; Schmelzle SM; van Zandbergen G; Fürstner A; Ziebuhr J; Heine A; Müller-Ruttloff C; Grünweller A
    Heliyon; 2024 Jul; 10(13):e33409. PubMed ID: 39035482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein.
    Jin C; Rajabi H; Rodrigo CM; Porco JA; Kufe D
    Oncogene; 2013 Apr; 32(17):2179-88. PubMed ID: 22689062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9.
    Park H; Drevelle O; Daviau A; Senta H; Bergeron E; Faucheux N
    Anticancer Drugs; 2013 Mar; 24(3):278-90. PubMed ID: 23262982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. eIF4A1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
    Steinmann SM; Sánchez-Martín A; Tanzer E; Cigliano A; Pes GM; Simile MM; Desaubry L; Marin JJG; Evert M; Calvisi DF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers.
    Xue C; Gu X; Li G; Bao Z; Li L
    Front Cell Dev Biol; 2021; 9():711965. PubMed ID: 34869305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.
    Oblinger JL; Burns SS; Huang J; Pan L; Ren Y; Shen R; Kinghorn AD; Welling DB; Chang LS
    Exp Neurol; 2018 Jan; 299(Pt B):299-307. PubMed ID: 28610844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.
    Iwasaki S; Iwasaki W; Takahashi M; Sakamoto A; Watanabe C; Shichino Y; Floor SN; Fujiwara K; Mito M; Dodo K; Sodeoka M; Imataka H; Honma T; Fukuzawa K; Ito T; Ingolia NT
    Mol Cell; 2019 Feb; 73(4):738-748.e9. PubMed ID: 30595437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amidino-rocaglates (ADRs), a class of synthetic rocaglates, are potent inhibitors of SARS-CoV-2 replication through inhibition of viral protein synthesis.
    Keiser PT; Zhang W; Ricca M; Wacquiez A; Grimins A; Cencic R; Patten JJ; Shah P; Padilha E; Connor JH; Pelletier J; Lyons SM; Saeed M; Brown LE; Porco JA; Davey RA
    Antiviral Res; 2024 Oct; 230():105976. PubMed ID: 39117283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of epidermal growth factor receptor kinase inhibition on radiation response in canine osteosarcoma cells.
    Mantovani FB; Morrison JA; Mutsaers AJ
    BMC Vet Res; 2016 May; 12():82. PubMed ID: 27245053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
    Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
    Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. eIF4A RNA Helicase Associates with Cyclin-Dependent Protein Kinase A in Proliferating Cells and Is Modulated by Phosphorylation.
    Bush MS; Pierrat O; Nibau C; Mikitova V; Zheng T; Corke FM; Vlachonasios K; Mayberry LK; Browning KS; Doonan JH
    Plant Physiol; 2016 Sep; 172(1):128-40. PubMed ID: 27388680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.
    Nilewski C; Michels TD; Xiang AX; Packard GK; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Ernst JT; Reich SH
    Org Lett; 2020 Aug; 22(16):6257-6261. PubMed ID: 32806219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel Bcr-Abl-mTOR-eIF4A axis regulates IRES-mediated translation of LEF-1.
    Tsai BP; Jimenez J; Lim S; Fitzgerald KD; Zhang M; Chuah CT; Axelrod H; Wilson L; Ong ST; Semler BL; Waterman ML
    Open Biol; 2014 Nov; 4(11):140180. PubMed ID: 25392452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Programmed cell death 4 mechanism of action: The model to be updated?
    Vikhreva PN; Kalinichenko SV; Korobko IV
    Cell Cycle; 2017 Oct; 16(19):1761-1764. PubMed ID: 28853972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zotatifin, an eIF4A-Selective Inhibitor, Blocks Tumor Growth in Receptor Tyrosine Kinase Driven Tumors.
    Gerson-Gurwitz A; Young NP; Goel VK; Eam B; Stumpf CR; Chen J; Fish S; Barrera M; Sung E; Staunton J; Chiang GG; Webster KR; Thompson PA
    Front Oncol; 2021; 11():766298. PubMed ID: 34900714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity.
    Obermann W; Friedrich A; Madhugiri R; Klemm P; Mengel JP; Hain T; Pleschka S; Wendel HG; Hartmann RK; Schiffmann S; Ziebuhr J; Müller C; Grünweller A
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Cardiac Glycosides as Novel Inhibitors of eIF4A1-Mediated Translation in Triple-Negative Breast Cancer Cells.
    Howard CM; Estrada M; Terrero D; Tiwari AK; Raman D
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.